Skip to main content
. 2022 May 23;18(21):2615–2622. doi: 10.2217/fon-2022-0285

Table 1. . Chemotherapy regimens.

First-line options:  
FLOT Oxaliplatin 85 mg/m2 i.v. on day 1
Docetaxel 50 mg/m2 i.v. on day 1
Leucovorin 200 mg/m2 i.v. on day 1
Fluorouracil 2600 mg/m2 continuous infusion over 24 h daily on day 1
Every 14 days
FOLFOX Oxaliplatin 85 mg/m2 i.v. on day 1
Leucovorin 400 mg/m2 i.v. on day 1
Fluorouracil 400 mg/m2 i.v. push on day 1
Fluorouracil 1200 mg/m2 continuous infusion over
24 h daily on days 1 and 2
Every 14 days
Second-line options:  
FOLFIRI Irinotecan 180 mg/m2 i.v. on day 1
Leucovorin 400 mg/m2 i.v. on day 1
Fluorouracil 400 mg/m2 i.v. push on day 1
Fluorouracil 1200 mg/m2 continuous infusion over
24 h daily on days 1 and 2
Every 14 days
FOLFIRINOX Oxaliplatin 85 mg/m2 i.v. on day 1
Irinotecan 150 mg/m2 i.v. on day 1
Leucovorin 200 mg/m2 i.v. on day 1
Fluorouracil 1200 mg/m2 continuous infusion over
24 h daily on days 1 and 2
Every 14 days
Paclitaxel with carboplatin Paclitaxel 200 mg/m2 i.v. on day 1
Carboplatin AUC 5 i.v. on day 1
Every 21 days
Paclitaxel Paclitaxel 80 mg/m2 i.v. on days 1, 8, 15
Every 28 days
Docetaxel and irinotecan Docetaxel 35 mg/m2 i.v. on days 1 and 8
Irinotecan 50 mg/m2 i.v. on days 1 and 8
Every 21 days
Docetaxel 75 mg/m2 i.v. on day 1
Every 21 days
Docetaxel 150 mg/m2 i.v. on day 1
Every 14 days
Additional therapy options:  
Nivolumab 240 mg i.v. on day 1 every 14 days, or
360 mg i.v. on day 1 every 21 days, or
480 mg i.v. on day 1 every 28 days
Pembrolizumab 200 mg i.v. on day 1 every 21 days, or
400 mg i.v. on day 1 every 42 days

Alone or combined.

Alone or when added to a regimen above.

AUC: Area under the curve; FLOT: 5FU, leucovorin, oxaliplatin and docetaxel; h: Hour; i.v.: Intravenously.